Clinitech Laboratory Past Earnings Performance
Past criteria checks 0/6
Clinitech Laboratory has been growing earnings at an average annual rate of 0.1%, while the Healthcare industry saw earnings growing at 28.8% annually. Revenues have been growing at an average rate of 9.3% per year. Clinitech Laboratory's return on equity is 10.5%, and it has net margins of 5.8%.
Key information
0.1%
Earnings growth rate
-0.9%
EPS growth rate
| Healthcare Industry Growth | 29.4% |
| Revenue growth rate | 9.3% |
| Return on equity | 10.5% |
| Net Margin | 5.8% |
| Last Earnings Update | 31 Mar 2024 |
Recent past performance updates
No updates
Recent updates
Revenue & Expenses Breakdown
How Clinitech Laboratory makes and spends money. Based on latest reported earnings, on an LTM basis.
Earnings and Revenue History
| Date | Revenue | Earnings | G+A Expenses | R&D Expenses |
|---|---|---|---|---|
| 31 Mar 24 | 64 | 4 | 23 | 0 |
| 31 Mar 23 | 63 | 6 | 20 | 0 |
| 31 Mar 22 | 64 | 5 | 18 | 0 |
| 31 Mar 21 | 46 | 4 | 12 | 0 |
Quality Earnings: 544220 has a high level of non-cash earnings.
Growing Profit Margin: 544220's current net profit margins (5.8%) are lower than last year (9.7%).
Free Cash Flow vs Earnings Analysis
Past Earnings Growth Analysis
Earnings Trend: Insufficient data to determine if 544220's year-on-year earnings growth rate was positive over the past 5 years.
Accelerating Growth: 544220's has had negative earnings growth over the past year, so it can't be compared to its 5-year average.
Earnings vs Industry: 544220 had negative earnings growth (-39.5%) over the past year, making it difficult to compare to the Healthcare industry average (30.6%).
Return on Equity
High ROE: 544220's Return on Equity (10.5%) is considered low.